• SENSEX 77,966.35
    -187.90 (--0.24%)
  • BANKNIFTY 57,885.85
    439.60 (+0.77%)
  • Tenneco Clean
    524.00 437.85(%)
  • Finolex Cables
    1,375.00 1,375.00(%)
  • Godrej Consumer
    908.00 908.00(%)
  • Max Healthcare
    1,002.00 903.50(%)
  • HDFC Bank
    722.00 722.00(%)
  • TD Power Systems
    1,529.00 1,529.00(%)
  • SBI
    1,085.00 1,234.80(%)
  • Grasim Inds
    3,270.00 2,504.35(%)
  • Hindustan Copper
    569.85 759.20(%)
  • Hindalco Inds.
    1,088.25 1,179.35(%)
  • TCS
    2,301.10 1,976.00(%)
  • Multi Comm. Exc.
    2,987.85 3,479.80(%)
  • Hind.Aeronautics
    5,054.40 5,054.40(%)
  • Fortis Health.
    879.30 767.30(%)
  • Apar Inds.
    18,432.40 18,432.40(%)
  • Axis Bank
    1,216.80 1,041.30(%)
  • Billionbrains
    197.95 227.00(%)
  • Marksans Pharma
    319.90 319.90(%)
  • Ardee Industries
    73.60 73.60(%)
  • LG Electronics
    1,584.00 1,736.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Innova Captab Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 74713.0
  • ISIN : INE0DUT01020
1,012.20 -7 (-0.66%)
  • As on 12 Aug 2026 (EOD)
  • Today’s Low

    986.50
  • Today’s High

    1,120.00
  • Open

    1,100.10
  • Perv Close

    1,018.90
  • 52W Low

    622.00
  • 52W High

    1,120.00

Key Indicators

  • P/E(TTM)

    69.30

  • Mar.Cap (₹Cr.)

    5,792.31

  • Div & Yield %

    0.20

  • Book Value(₹)

    154.94

  • Debt-Equity Ratio

    -0.66

  • AGM Date

    12-Aug-2026

  • EPS

    14.62

  • P/E Ratio

    69.30

Financials Ratios

  • Debt-Equity Ratio

    0.38

  • Mar.Cap (₹Cr.)

    5,792.31

  • RONW (%)

    17.04

  • ROCE (%)

    18.76

Score Board

  • Equity (₹ in Cr.)

    57.22

  • BV (₹)

    154.90

  • Sales( ₹ in Cr.)

    1,298.81

  • NP (in Cr.)

    83.68

  • NP Var(%)

    -7.0

  • Div%

    20.0

  • CPS (₹)

    21.20

  • EPS (₹)

    14.60

  • Traded Value (₹ in Lakhs)

    5,845.24

  • 52 Week High

    1,120.00

  • 52 Week Low

    622.00

  • Price BSE

    1021.0

  • Price NSE

    1,019.00

  • Market Capital( in Cr.)

    5,845.24

  • P/C Ratio

    48.30

  • P/E Ratio

    69.80

  • Price Vs.BV

    14.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,298.81 958.06 864.93 858.67 785.46 410.66
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,298.81 958.06 864.93 858.67 785.46 410.66
Other Income 13.24 16.78 10.72 8.73 2.86 1.37
Stock Adjustments 2.28 11.34 1.35 1.48 -1.00 -1.64
Total Income 1,314.33 986.18 877.00 868.88 787.32 410.39
EXPENDITURE :            
Raw Materials 728.91 552.98 506.91 529.83 607.88 309.06
Power and Fuel Cost 26.12 15.07 11.58 9.42 7.90 5.48
Employee Cost 111.09 62.74 50.11 43.60 36.30 22.22
Other Manufacturing Expenses 249.89 189.58 163.40 157.91 11.67 5.25
Selling and Administration Expenses 31.67 17.52 19.77 17.66 16.63 9.57
Miscellaneous Expenses 2.04 9.22 6.54 3.21 5.57 2.96
Employee Benefit Expenses 111.09 62.74 50.11 43.60 36.30 22.22
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,149.72 847.11 758.31 761.63 685.95 354.54
Operating Profit 164.61 139.08 118.69 107.26 101.37 55.86
Interest 15.42 2.17 13.59 18.30 5.33 3.93
Gross Profit 149.19 136.91 105.10 88.96 96.04 51.93
Depreciation 37.37 17.02 11.40 10.66 7.40 5.59
Profit Before Tax 111.82 119.89 93.70 78.30 88.64 46.34
Current Tax 17.77 22.00 25.18 18.86 21.80 11.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 10.37 8.42 0.35 1.89 0.66 0.35
Reported Net Profit 83.69 89.47 68.16 57.55 66.18 34.50
Extraordinary Items 0.01 -0.06 -1.38 1.66 -0.01 0.11
Adjusted Net Profit 83.68 89.53 69.54 55.89 66.19 34.39
Adjustment below Net Profit -0.06 -0.22 0.28 -36.06 -0.17 -0.08
P & L Balance brought forward 377.96 288.71 220.28 198.78 132.78 98.35
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 11.45 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 450.15 377.96 288.71 220.28 198.78 132.78
Dividend 11.45 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 20.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 2.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 14.63 15.63 11.91 11.99 55.15 287.50
Earnings Per Share(Adj)-Unit Curr 14.63 15.63 11.91 - - -
Book Value 154.94 142.06 126.47 55.90 175.69 1,206.84
Book Value(Adj)-Unit Curr 154.94 142.06 126.47 - - -

Shareholding Pattern

  • Promoter Group

    50.90%

  • Public Share Holding

    49.10%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 29,127,371 50.90 29,127,371 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 29,127,371 50.90 29,127,371 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 193,615 0.34 193,615 24
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 830,214 1.45 830,214 1
Mutual Funds / UTI 5,253,536 9.18 5,253,536 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 5,315,381 9.29 5,315,381 10
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 11,592,746 20.26 11,592,746 42
2] Non Institution
Bodies Corporate 625,365 1.09 625,365 276
Clearing Members 264 0.00 264 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 172,138 0.30 172,138 628
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 130,994 0.23 130,994 881
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 12,627,083 22.07 12,627,083 10
Individuals holding nominal share capital up to Rs. 1 lakh 2,948,747 5.15 2,948,747 34,037
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 221 0.00 221 1
Others 0 0.00 0 0
Sub Total 16,504,812 28.84 16,504,812 35,834
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 57,224,929 100.00 57,224,929 35,881

Company Background

Innova Captab LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Innova Captab Ltd
  • BSE Code : 74713.0
  • ISIN : INE0DUT01020
  • Incorporation Year

    2005

  • Registered Office

    Office No 1513 Satra Plaza
    Plot No 19-20 Sector 19D Vashi, Navi Mumbai,
    Maharashtra-400703

  • Telephone

    91-22-2564 2095

  • FAX

  • Chairman

    Manoj Kumar Lohariwala

  • Managing Director

    Vinay Kumar Lohariwala

  • Company Secretary

    NEEHARIKA SHUKLA

  • Auditor

    BSR & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Innova Captab Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Innova Captab 1,013.10 1,312.06 1,298.81 69.25 10.78
Abbott India 28,146.90 7,217.19 6,929.05 38.54 43.78
Astrazeneca Phar 7,905.70 2,304.07 2,275.58 116.52 27.86
P & G Health Ltd 5,953.30 944.52 934.17 27.69 71.75
Glaxosmi. Pharma 2,619.65 3,932.76 3,790.20 41.85 58.17
Cipla 1,461.55 20,102.60 18,979.95 38.41 13.88
Bliss GVS Pharma 488.20 773.53 729.81 53.53 12.51
Amrutanjan Healt 487.20 469.50 451.82 24.32 21.89
Fermenta Biotec. 473.40 474.15 450.25 21.68 18.77
Guj. Themis Bio. 352.85 152.47 150.80 78.94 27.21
Ambalal Sarabhai 44.93 19.52 3.94 31.42 6.77